참고문헌
- Abbaszadegan MR, Tavasoli A, Velayati A, et al (2007). Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran. World J Gastroenterol, 14, 1528-33.
- Beroud C, Soussi T (1998). p53 gene mutation: software and database. Nucleic Acids Res, 1, 200-4.
- Bosch LJ, Carvalho B, Fijneman RJ, et al (2011). Molecular tests for colorectal cancer screening. Clin Colorectal Cancer, 1, 8-23.
- Boynton KA, Summerhayes IC, Ahlquist DA, et al (2003). DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clin Chem, 49, 1058-65. https://doi.org/10.1373/49.7.1058
- Burt RW. (2010). Colorectal cancer screening. Curr Opin Gastroenterol, 26, 466-70. https://doi.org/10.1097/MOG.0b013e32833d1733
- Calistri D, Rengucci C, Lattuneddu A, et al (2004). Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool. Neoplasia, 6, 536-40. https://doi.org/10.1593/neo.04190
- Calistri D, Rengucci C, Molinari C, et al (2009). Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer. Cell Oncol, 31, 11-7.
- Chen WD, Han ZJ, Skoletsky J, et al (2005). Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst, 3, 1124-32.
- Ekelund G, Manjer J, Zackrisson S (2010). Population-based screening for colorectal cancer with faecal occult blood test--do we really have enough evidence? Int J Colorectal Dis, 25, 1269-75. https://doi.org/10.1007/s00384-010-1027-1
- Harmy M, Norwati D, Noor NM, et al (2011). Knowledge and attitude of colorectal cancer screening among moderate risk patients in west Malaysia. APJCP, 12, 1957-60.
- Kalimutho M, Del Vecchio Blanco G, Cretella M, et al (2011). A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection. Int J Colorectal Dis, 26, 583-92. https://doi.org/10.1007/s00384-010-1128-x
- Kanthan R, Senger J-L, and Kanthan SC (2012). Fecal molecular markers for colorectal cancer screening. Gastroenterology Research and Practice, ?, 1-15.
- Kerr J, Day P, Broadstock M, et al (2007). Systematic review of the effectiveness of population screening for colorectal cancer. N Z Med J, 20, 2629.
- Klaassen CH, Jeunink MA, Prinsen CF, et al (2003). Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer. Clin Chem, 49, 1185-7. https://doi.org/10.1373/49.7.1185
- NCPR-CRC. (2010). http://www.crc.gov.my/pdf/NCPR2010.pdf.
- Olson J, Whitney DH, Durkee K, et al (2005). DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests. Diagn Mol Pathol, 14, 183-91. https://doi.org/10.1097/01.pas.0000176768.18423.7e
- Young GP, Bosch LJ. (2011). Fecal tests: From blood to molecular markers. Curr Colorectal Cancer Rep, 7, 62-70. https://doi.org/10.1007/s11888-010-0084-8
피인용 문헌
- Virtual gastrointestinal colonoscopy in combination with large bowel endoscopy: Clinical application vol.20, pp.38, 2014, https://doi.org/10.3748/wjg.v20.i38.13820
- The Diagnostic Performance of Stool DNA Testing for Colorectal Cancer vol.95, pp.5, 2016, https://doi.org/10.1097/MD.0000000000002129